<table frame="void" id="t303" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="Gfd9ead10-25ac-4d57-bf02-bab55766fece">TABLE 4: MEAN ± SD STEADY STATE SIROLIMUS PHARMACOKINETIC PARAMETERS IN LOW- TO MODERATE-IMMUNOLOGIC RISK ADULT RENAL TRANSPLANT PATIENTS FOLLOWING RAPAMUNE 2 MG DAILY<sup>a,b</sup>
</caption>
<colgroup>
<col width="208px"></col>
<col width="208px"></col>
<col width="208px"></col>
</colgroup>
<thead valign="bottom">
<tr valign="bottom">
<th stylecode="TopruleRULE" valign="bottom"> </th>
<th align="center" colspan="2" stylecode="TopruleRULE" valign="bottom">Multiple<br/>Dose (daily dose)</th>
</tr>
<tr valign="bottom">
<th stylecode="BOTRULE" valign="bottom"> </th>
<th align="center" stylecode="BOTRULE" valign="bottom">Solution</th>
<th align="center" stylecode="BOTRULE" valign="bottom">Tablets</th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="3">a: In presence of cyclosporine administered 4 hours before Rapamune dosing.<paragraph id="G9290f656-7a66-436c-b62f-973d8a75169c"> b: Based on data collected at months 1 and 3 post-transplantation.</paragraph>
<paragraph id="G85737957-a065-46d2-ae06-0fa63cfe00fe"> c: Average C<sub>min</sub> over 6 months.</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td>C<sub>max</sub> (ng/mL)</td>
<td align="center">14.4 ± 5.3</td>
<td align="center">15.0 ± 4.9</td>
</tr>
<tr>
<td>t<sub>max</sub> (hr)</td>
<td align="center">2.1 ± 0.8</td>
<td align="center">3.5 ± 2.4</td>
</tr>
<tr>
<td>AUC (ng•h/mL)</td>
<td align="center">194 ± 78</td>
<td align="center">230 ± 67</td>
</tr>
<tr>
<td>C<sub>min</sub> (ng/mL)<sup>c</sup>
</td>
<td align="center">7.1 ± 3.5</td>
<td align="center">7.6 ± 3.1</td>
</tr>
<tr>
<td>CL/F (mL/h/kg)</td>
<td align="center">173 ± 50</td>
<td align="center">139 ± 63</td>
</tr>
</tbody>
</table>